The Helsinki Unruptured Intracranial Aneurysm Quality of Care Study

Last updated: October 8, 2024
Sponsor: Helsinki University Central Hospital
Overall Status: Active - Not Recruiting

Phase

N/A

Condition

Aneurysm

Treatment

Surgery

Endovascular

Clinical Study ID

NCT06147102
HUS/216/2023
  • All Genders

Study Summary

A research-initiated prospective cohort study with the aim to assess the effectivity, safety and long-term outcomes after surgical and endovascular treatment of unruptured intracranial aneurysms. All consecutive patients with a non-ruptured intracranial aneurysms treated at Helsinki University Hospital will be included. Safety is measured by postoperative magnetic resonance imaging (MRI) taken 1-3 days after the treatment, treatment-related complications and functional outcome at three months. Effectiveness is measured by angiographic results and assessment of long-term bleeding from the treated aneurysm. Other outcomes include risk of developing epilepsy, getting a new stroke, and dementia on long-term follow-up.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • All patients with an unruptured intracranial aneurysm undergoing treatment

Exclusion

Exclusion Criteria:

  • Arteriovenous malformation related intracranial aneurysm

  • Moyamoya-disease related intracranial aneurysm

  • Ruptured intracranial aneurysm

Study Design

Total Participants: 173
Treatment Group(s): 2
Primary Treatment: Surgery
Phase:
Study Start date:
January 01, 2023
Estimated Completion Date:
December 31, 2027

Connect with a study center

  • Helsinki University Hospital

    Helsinki, Uusimaa 00029 HUS
    Finland

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.